Chondroprotective Agent Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Chondroprotective Agent in global, including the following market information:
Global Chondroprotective Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chondroprotective Agent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chondroprotective Agent companies in 2021 (%)
The global Chondroprotective Agent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sodium Hyaluronate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chondroprotective Agent include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chondroprotective Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chondroprotective Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chondroprotective Agent Market Segment Percentages, by Type, 2021 (%)
Global Chondroprotective Agent Market Segment Percentages, by Application, 2021 (%)
Global Chondroprotective Agent Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Chondroprotective Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chondroprotective Agent revenues share in global market, 2021 (%)
Key companies Chondroprotective Agent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chondroprotective Agent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Chondroprotective Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chondroprotective Agent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chondroprotective Agent companies in 2021 (%)
The global Chondroprotective Agent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sodium Hyaluronate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chondroprotective Agent include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chondroprotective Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chondroprotective Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chondroprotective Agent Market Segment Percentages, by Type, 2021 (%)
- Sodium Hyaluronate
- Glucosamine Sulfate
- Chondroitin Sulfate
Global Chondroprotective Agent Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Ambulatory Surgery Center
Global Chondroprotective Agent Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Chondroprotective Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chondroprotective Agent revenues share in global market, 2021 (%)
Key companies Chondroprotective Agent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chondroprotective Agent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- SANXIN
- WanTuMing Biological
- TSI Group
- Yantai Dongcheng
- Focus Chem
- YBCC
- Runxin Biotechnology
- ISBA
- Huiwen
- QJBCHINA
- Meitek (Synutra International)
- Hengjie Bio-Pharmaceuticals
- Nippon Zoki
- GGI
- Summit Nutritionals
- Sioux Pharm
- Ruikangda Biochemical
- Guanglong Biochem
- Pacific Rainbow
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Chondroprotective Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chondroprotective Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHONDROPROTECTIVE AGENT OVERALL MARKET SIZE
2.1 Global Chondroprotective Agent Market Size: 2021 VS 2028
2.2 Global Chondroprotective Agent Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chondroprotective Agent Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chondroprotective Agent Players in Global Market
3.2 Top Global Chondroprotective Agent Companies Ranked by Revenue
3.3 Global Chondroprotective Agent Revenue by Companies
3.4 Global Chondroprotective Agent Sales by Companies
3.5 Global Chondroprotective Agent Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chondroprotective Agent Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chondroprotective Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chondroprotective Agent Players in Global Market
3.8.1 List of Global Tier 1 Chondroprotective Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Chondroprotective Agent Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chondroprotective Agent Market Size Markets, 2021 & 2028
4.1.2 Sodium Hyaluronate
4.1.3 Glucosamine Sulfate
4.1.4 Chondroitin Sulfate
4.2 By Type - Global Chondroprotective Agent Revenue & Forecasts
4.2.1 By Type - Global Chondroprotective Agent Revenue, 2017-2022
4.2.2 By Type - Global Chondroprotective Agent Revenue, 2023-2028
4.2.3 By Type - Global Chondroprotective Agent Revenue Market Share, 2017-2028
4.3 By Type - Global Chondroprotective Agent Sales & Forecasts
4.3.1 By Type - Global Chondroprotective Agent Sales, 2017-2022
4.3.2 By Type - Global Chondroprotective Agent Sales, 2023-2028
4.3.3 By Type - Global Chondroprotective Agent Sales Market Share, 2017-2028
4.4 By Type - Global Chondroprotective Agent Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chondroprotective Agent Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Ambulatory Surgery Center
5.2 By Application - Global Chondroprotective Agent Revenue & Forecasts
5.2.1 By Application - Global Chondroprotective Agent Revenue, 2017-2022
5.2.2 By Application - Global Chondroprotective Agent Revenue, 2023-2028
5.2.3 By Application - Global Chondroprotective Agent Revenue Market Share, 2017-2028
5.3 By Application - Global Chondroprotective Agent Sales & Forecasts
5.3.1 By Application - Global Chondroprotective Agent Sales, 2017-2022
5.3.2 By Application - Global Chondroprotective Agent Sales, 2023-2028
5.3.3 By Application - Global Chondroprotective Agent Sales Market Share, 2017-2028
5.4 By Application - Global Chondroprotective Agent Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chondroprotective Agent Market Size, 2021 & 2028
6.2 By Region - Global Chondroprotective Agent Revenue & Forecasts
6.2.1 By Region - Global Chondroprotective Agent Revenue, 2017-2022
6.2.2 By Region - Global Chondroprotective Agent Revenue, 2023-2028
6.2.3 By Region - Global Chondroprotective Agent Revenue Market Share, 2017-2028
6.3 By Region - Global Chondroprotective Agent Sales & Forecasts
6.3.1 By Region - Global Chondroprotective Agent Sales, 2017-2022
6.3.2 By Region - Global Chondroprotective Agent Sales, 2023-2028
6.3.3 By Region - Global Chondroprotective Agent Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chondroprotective Agent Revenue, 2017-2028
6.4.2 By Country - North America Chondroprotective Agent Sales, 2017-2028
6.4.3 US Chondroprotective Agent Market Size, 2017-2028
6.4.4 Canada Chondroprotective Agent Market Size, 2017-2028
6.4.5 Mexico Chondroprotective Agent Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chondroprotective Agent Revenue, 2017-2028
6.5.2 By Country - Europe Chondroprotective Agent Sales, 2017-2028
6.5.3 Germany Chondroprotective Agent Market Size, 2017-2028
6.5.4 France Chondroprotective Agent Market Size, 2017-2028
6.5.5 U.K. Chondroprotective Agent Market Size, 2017-2028
6.5.6 Italy Chondroprotective Agent Market Size, 2017-2028
6.5.7 Russia Chondroprotective Agent Market Size, 2017-2028
6.5.8 Nordic Countries Chondroprotective Agent Market Size, 2017-2028
6.5.9 Benelux Chondroprotective Agent Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chondroprotective Agent Revenue, 2017-2028
6.6.2 By Region - Asia Chondroprotective Agent Sales, 2017-2028
6.6.3 China Chondroprotective Agent Market Size, 2017-2028
6.6.4 Japan Chondroprotective Agent Market Size, 2017-2028
6.6.5 South Korea Chondroprotective Agent Market Size, 2017-2028
6.6.6 Southeast Asia Chondroprotective Agent Market Size, 2017-2028
6.6.7 India Chondroprotective Agent Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chondroprotective Agent Revenue, 2017-2028
6.7.2 By Country - South America Chondroprotective Agent Sales, 2017-2028
6.7.3 Brazil Chondroprotective Agent Market Size, 2017-2028
6.7.4 Argentina Chondroprotective Agent Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chondroprotective Agent Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chondroprotective Agent Sales, 2017-2028
6.8.3 Turkey Chondroprotective Agent Market Size, 2017-2028
6.8.4 Israel Chondroprotective Agent Market Size, 2017-2028
6.8.5 Saudi Arabia Chondroprotective Agent Market Size, 2017-2028
6.8.6 UAE Chondroprotective Agent Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SANXIN
7.1.1 SANXIN Corporate Summary
7.1.2 SANXIN Business Overview
7.1.3 SANXIN Chondroprotective Agent Major Product Offerings
7.1.4 SANXIN Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.1.5 SANXIN Key News
7.2 WanTuMing Biological
7.2.1 WanTuMing Biological Corporate Summary
7.2.2 WanTuMing Biological Business Overview
7.2.3 WanTuMing Biological Chondroprotective Agent Major Product Offerings
7.2.4 WanTuMing Biological Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.2.5 WanTuMing Biological Key News
7.3 TSI Group
7.3.1 TSI Group Corporate Summary
7.3.2 TSI Group Business Overview
7.3.3 TSI Group Chondroprotective Agent Major Product Offerings
7.3.4 TSI Group Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.3.5 TSI Group Key News
7.4 Yantai Dongcheng
7.4.1 Yantai Dongcheng Corporate Summary
7.4.2 Yantai Dongcheng Business Overview
7.4.3 Yantai Dongcheng Chondroprotective Agent Major Product Offerings
7.4.4 Yantai Dongcheng Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.4.5 Yantai Dongcheng Key News
7.5 Focus Chem
7.5.1 Focus Chem Corporate Summary
7.5.2 Focus Chem Business Overview
7.5.3 Focus Chem Chondroprotective Agent Major Product Offerings
7.5.4 Focus Chem Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.5.5 Focus Chem Key News
7.6 YBCC
7.6.1 YBCC Corporate Summary
7.6.2 YBCC Business Overview
7.6.3 YBCC Chondroprotective Agent Major Product Offerings
7.6.4 YBCC Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.6.5 YBCC Key News
7.7 Runxin Biotechnology
7.7.1 Runxin Biotechnology Corporate Summary
7.7.2 Runxin Biotechnology Business Overview
7.7.3 Runxin Biotechnology Chondroprotective Agent Major Product Offerings
7.7.4 Runxin Biotechnology Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.7.5 Runxin Biotechnology Key News
7.8 ISBA
7.8.1 ISBA Corporate Summary
7.8.2 ISBA Business Overview
7.8.3 ISBA Chondroprotective Agent Major Product Offerings
7.8.4 ISBA Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.8.5 ISBA Key News
7.9 Huiwen
7.9.1 Huiwen Corporate Summary
7.9.2 Huiwen Business Overview
7.9.3 Huiwen Chondroprotective Agent Major Product Offerings
7.9.4 Huiwen Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.9.5 Huiwen Key News
7.10 QJBCHINA
7.10.1 QJBCHINA Corporate Summary
7.10.2 QJBCHINA Business Overview
7.10.3 QJBCHINA Chondroprotective Agent Major Product Offerings
7.10.4 QJBCHINA Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.10.5 QJBCHINA Key News
7.11 Meitek (Synutra International)
7.11.1 Meitek (Synutra International) Corporate Summary
7.11.2 Meitek (Synutra International) Chondroprotective Agent Business Overview
7.11.3 Meitek (Synutra International) Chondroprotective Agent Major Product Offerings
7.11.4 Meitek (Synutra International) Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.11.5 Meitek (Synutra International) Key News
7.12 Hengjie Bio-Pharmaceuticals
7.12.1 Hengjie Bio-Pharmaceuticals Corporate Summary
7.12.2 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Business Overview
7.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Major Product Offerings
7.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.12.5 Hengjie Bio-Pharmaceuticals Key News
7.13 Nippon Zoki
7.13.1 Nippon Zoki Corporate Summary
7.13.2 Nippon Zoki Chondroprotective Agent Business Overview
7.13.3 Nippon Zoki Chondroprotective Agent Major Product Offerings
7.13.4 Nippon Zoki Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.13.5 Nippon Zoki Key News
7.14 GGI
7.14.1 GGI Corporate Summary
7.14.2 GGI Business Overview
7.14.3 GGI Chondroprotective Agent Major Product Offerings
7.14.4 GGI Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.14.5 GGI Key News
7.15 Summit Nutritionals
7.15.1 Summit Nutritionals Corporate Summary
7.15.2 Summit Nutritionals Business Overview
7.15.3 Summit Nutritionals Chondroprotective Agent Major Product Offerings
7.15.4 Summit Nutritionals Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.15.5 Summit Nutritionals Key News
7.16 Sioux Pharm
7.16.1 Sioux Pharm Corporate Summary
7.16.2 Sioux Pharm Business Overview
7.16.3 Sioux Pharm Chondroprotective Agent Major Product Offerings
7.16.4 Sioux Pharm Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.16.5 Sioux Pharm Key News
7.17 Ruikangda Biochemical
7.17.1 Ruikangda Biochemical Corporate Summary
7.17.2 Ruikangda Biochemical Business Overview
7.17.3 Ruikangda Biochemical Chondroprotective Agent Major Product Offerings
7.17.4 Ruikangda Biochemical Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.17.5 Ruikangda Biochemical Key News
7.18 Guanglong Biochem
7.18.1 Guanglong Biochem Corporate Summary
7.18.2 Guanglong Biochem Business Overview
7.18.3 Guanglong Biochem Chondroprotective Agent Major Product Offerings
7.18.4 Guanglong Biochem Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.18.5 Guanglong Biochem Key News
7.19 Pacific Rainbow
7.19.1 Pacific Rainbow Corporate Summary
7.19.2 Pacific Rainbow Business Overview
7.19.3 Pacific Rainbow Chondroprotective Agent Major Product Offerings
7.19.4 Pacific Rainbow Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.19.5 Pacific Rainbow Key News
8 GLOBAL CHONDROPROTECTIVE AGENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chondroprotective Agent Production Capacity, 2017-2028
8.2 Chondroprotective Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Chondroprotective Agent Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHONDROPROTECTIVE AGENT SUPPLY CHAIN ANALYSIS
10.1 Chondroprotective Agent Industry Value Chain
10.2 Chondroprotective Agent Upstream Market
10.3 Chondroprotective Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chondroprotective Agent Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Chondroprotective Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chondroprotective Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHONDROPROTECTIVE AGENT OVERALL MARKET SIZE
2.1 Global Chondroprotective Agent Market Size: 2021 VS 2028
2.2 Global Chondroprotective Agent Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chondroprotective Agent Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chondroprotective Agent Players in Global Market
3.2 Top Global Chondroprotective Agent Companies Ranked by Revenue
3.3 Global Chondroprotective Agent Revenue by Companies
3.4 Global Chondroprotective Agent Sales by Companies
3.5 Global Chondroprotective Agent Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chondroprotective Agent Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chondroprotective Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chondroprotective Agent Players in Global Market
3.8.1 List of Global Tier 1 Chondroprotective Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Chondroprotective Agent Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chondroprotective Agent Market Size Markets, 2021 & 2028
4.1.2 Sodium Hyaluronate
4.1.3 Glucosamine Sulfate
4.1.4 Chondroitin Sulfate
4.2 By Type - Global Chondroprotective Agent Revenue & Forecasts
4.2.1 By Type - Global Chondroprotective Agent Revenue, 2017-2022
4.2.2 By Type - Global Chondroprotective Agent Revenue, 2023-2028
4.2.3 By Type - Global Chondroprotective Agent Revenue Market Share, 2017-2028
4.3 By Type - Global Chondroprotective Agent Sales & Forecasts
4.3.1 By Type - Global Chondroprotective Agent Sales, 2017-2022
4.3.2 By Type - Global Chondroprotective Agent Sales, 2023-2028
4.3.3 By Type - Global Chondroprotective Agent Sales Market Share, 2017-2028
4.4 By Type - Global Chondroprotective Agent Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chondroprotective Agent Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Ambulatory Surgery Center
5.2 By Application - Global Chondroprotective Agent Revenue & Forecasts
5.2.1 By Application - Global Chondroprotective Agent Revenue, 2017-2022
5.2.2 By Application - Global Chondroprotective Agent Revenue, 2023-2028
5.2.3 By Application - Global Chondroprotective Agent Revenue Market Share, 2017-2028
5.3 By Application - Global Chondroprotective Agent Sales & Forecasts
5.3.1 By Application - Global Chondroprotective Agent Sales, 2017-2022
5.3.2 By Application - Global Chondroprotective Agent Sales, 2023-2028
5.3.3 By Application - Global Chondroprotective Agent Sales Market Share, 2017-2028
5.4 By Application - Global Chondroprotective Agent Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chondroprotective Agent Market Size, 2021 & 2028
6.2 By Region - Global Chondroprotective Agent Revenue & Forecasts
6.2.1 By Region - Global Chondroprotective Agent Revenue, 2017-2022
6.2.2 By Region - Global Chondroprotective Agent Revenue, 2023-2028
6.2.3 By Region - Global Chondroprotective Agent Revenue Market Share, 2017-2028
6.3 By Region - Global Chondroprotective Agent Sales & Forecasts
6.3.1 By Region - Global Chondroprotective Agent Sales, 2017-2022
6.3.2 By Region - Global Chondroprotective Agent Sales, 2023-2028
6.3.3 By Region - Global Chondroprotective Agent Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chondroprotective Agent Revenue, 2017-2028
6.4.2 By Country - North America Chondroprotective Agent Sales, 2017-2028
6.4.3 US Chondroprotective Agent Market Size, 2017-2028
6.4.4 Canada Chondroprotective Agent Market Size, 2017-2028
6.4.5 Mexico Chondroprotective Agent Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chondroprotective Agent Revenue, 2017-2028
6.5.2 By Country - Europe Chondroprotective Agent Sales, 2017-2028
6.5.3 Germany Chondroprotective Agent Market Size, 2017-2028
6.5.4 France Chondroprotective Agent Market Size, 2017-2028
6.5.5 U.K. Chondroprotective Agent Market Size, 2017-2028
6.5.6 Italy Chondroprotective Agent Market Size, 2017-2028
6.5.7 Russia Chondroprotective Agent Market Size, 2017-2028
6.5.8 Nordic Countries Chondroprotective Agent Market Size, 2017-2028
6.5.9 Benelux Chondroprotective Agent Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chondroprotective Agent Revenue, 2017-2028
6.6.2 By Region - Asia Chondroprotective Agent Sales, 2017-2028
6.6.3 China Chondroprotective Agent Market Size, 2017-2028
6.6.4 Japan Chondroprotective Agent Market Size, 2017-2028
6.6.5 South Korea Chondroprotective Agent Market Size, 2017-2028
6.6.6 Southeast Asia Chondroprotective Agent Market Size, 2017-2028
6.6.7 India Chondroprotective Agent Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chondroprotective Agent Revenue, 2017-2028
6.7.2 By Country - South America Chondroprotective Agent Sales, 2017-2028
6.7.3 Brazil Chondroprotective Agent Market Size, 2017-2028
6.7.4 Argentina Chondroprotective Agent Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chondroprotective Agent Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chondroprotective Agent Sales, 2017-2028
6.8.3 Turkey Chondroprotective Agent Market Size, 2017-2028
6.8.4 Israel Chondroprotective Agent Market Size, 2017-2028
6.8.5 Saudi Arabia Chondroprotective Agent Market Size, 2017-2028
6.8.6 UAE Chondroprotective Agent Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SANXIN
7.1.1 SANXIN Corporate Summary
7.1.2 SANXIN Business Overview
7.1.3 SANXIN Chondroprotective Agent Major Product Offerings
7.1.4 SANXIN Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.1.5 SANXIN Key News
7.2 WanTuMing Biological
7.2.1 WanTuMing Biological Corporate Summary
7.2.2 WanTuMing Biological Business Overview
7.2.3 WanTuMing Biological Chondroprotective Agent Major Product Offerings
7.2.4 WanTuMing Biological Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.2.5 WanTuMing Biological Key News
7.3 TSI Group
7.3.1 TSI Group Corporate Summary
7.3.2 TSI Group Business Overview
7.3.3 TSI Group Chondroprotective Agent Major Product Offerings
7.3.4 TSI Group Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.3.5 TSI Group Key News
7.4 Yantai Dongcheng
7.4.1 Yantai Dongcheng Corporate Summary
7.4.2 Yantai Dongcheng Business Overview
7.4.3 Yantai Dongcheng Chondroprotective Agent Major Product Offerings
7.4.4 Yantai Dongcheng Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.4.5 Yantai Dongcheng Key News
7.5 Focus Chem
7.5.1 Focus Chem Corporate Summary
7.5.2 Focus Chem Business Overview
7.5.3 Focus Chem Chondroprotective Agent Major Product Offerings
7.5.4 Focus Chem Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.5.5 Focus Chem Key News
7.6 YBCC
7.6.1 YBCC Corporate Summary
7.6.2 YBCC Business Overview
7.6.3 YBCC Chondroprotective Agent Major Product Offerings
7.6.4 YBCC Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.6.5 YBCC Key News
7.7 Runxin Biotechnology
7.7.1 Runxin Biotechnology Corporate Summary
7.7.2 Runxin Biotechnology Business Overview
7.7.3 Runxin Biotechnology Chondroprotective Agent Major Product Offerings
7.7.4 Runxin Biotechnology Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.7.5 Runxin Biotechnology Key News
7.8 ISBA
7.8.1 ISBA Corporate Summary
7.8.2 ISBA Business Overview
7.8.3 ISBA Chondroprotective Agent Major Product Offerings
7.8.4 ISBA Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.8.5 ISBA Key News
7.9 Huiwen
7.9.1 Huiwen Corporate Summary
7.9.2 Huiwen Business Overview
7.9.3 Huiwen Chondroprotective Agent Major Product Offerings
7.9.4 Huiwen Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.9.5 Huiwen Key News
7.10 QJBCHINA
7.10.1 QJBCHINA Corporate Summary
7.10.2 QJBCHINA Business Overview
7.10.3 QJBCHINA Chondroprotective Agent Major Product Offerings
7.10.4 QJBCHINA Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.10.5 QJBCHINA Key News
7.11 Meitek (Synutra International)
7.11.1 Meitek (Synutra International) Corporate Summary
7.11.2 Meitek (Synutra International) Chondroprotective Agent Business Overview
7.11.3 Meitek (Synutra International) Chondroprotective Agent Major Product Offerings
7.11.4 Meitek (Synutra International) Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.11.5 Meitek (Synutra International) Key News
7.12 Hengjie Bio-Pharmaceuticals
7.12.1 Hengjie Bio-Pharmaceuticals Corporate Summary
7.12.2 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Business Overview
7.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Major Product Offerings
7.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.12.5 Hengjie Bio-Pharmaceuticals Key News
7.13 Nippon Zoki
7.13.1 Nippon Zoki Corporate Summary
7.13.2 Nippon Zoki Chondroprotective Agent Business Overview
7.13.3 Nippon Zoki Chondroprotective Agent Major Product Offerings
7.13.4 Nippon Zoki Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.13.5 Nippon Zoki Key News
7.14 GGI
7.14.1 GGI Corporate Summary
7.14.2 GGI Business Overview
7.14.3 GGI Chondroprotective Agent Major Product Offerings
7.14.4 GGI Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.14.5 GGI Key News
7.15 Summit Nutritionals
7.15.1 Summit Nutritionals Corporate Summary
7.15.2 Summit Nutritionals Business Overview
7.15.3 Summit Nutritionals Chondroprotective Agent Major Product Offerings
7.15.4 Summit Nutritionals Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.15.5 Summit Nutritionals Key News
7.16 Sioux Pharm
7.16.1 Sioux Pharm Corporate Summary
7.16.2 Sioux Pharm Business Overview
7.16.3 Sioux Pharm Chondroprotective Agent Major Product Offerings
7.16.4 Sioux Pharm Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.16.5 Sioux Pharm Key News
7.17 Ruikangda Biochemical
7.17.1 Ruikangda Biochemical Corporate Summary
7.17.2 Ruikangda Biochemical Business Overview
7.17.3 Ruikangda Biochemical Chondroprotective Agent Major Product Offerings
7.17.4 Ruikangda Biochemical Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.17.5 Ruikangda Biochemical Key News
7.18 Guanglong Biochem
7.18.1 Guanglong Biochem Corporate Summary
7.18.2 Guanglong Biochem Business Overview
7.18.3 Guanglong Biochem Chondroprotective Agent Major Product Offerings
7.18.4 Guanglong Biochem Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.18.5 Guanglong Biochem Key News
7.19 Pacific Rainbow
7.19.1 Pacific Rainbow Corporate Summary
7.19.2 Pacific Rainbow Business Overview
7.19.3 Pacific Rainbow Chondroprotective Agent Major Product Offerings
7.19.4 Pacific Rainbow Chondroprotective Agent Sales and Revenue in Global (2017-2022)
7.19.5 Pacific Rainbow Key News
8 GLOBAL CHONDROPROTECTIVE AGENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chondroprotective Agent Production Capacity, 2017-2028
8.2 Chondroprotective Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Chondroprotective Agent Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHONDROPROTECTIVE AGENT SUPPLY CHAIN ANALYSIS
10.1 Chondroprotective Agent Industry Value Chain
10.2 Chondroprotective Agent Upstream Market
10.3 Chondroprotective Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chondroprotective Agent Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Chondroprotective Agent in Global Market
Table 2. Top Chondroprotective Agent Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chondroprotective Agent Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chondroprotective Agent Revenue Share by Companies, 2017-2022
Table 5. Global Chondroprotective Agent Sales by Companies, (K Units), 2017-2022
Table 6. Global Chondroprotective Agent Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chondroprotective Agent Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Chondroprotective Agent Product Type
Table 9. List of Global Tier 1 Chondroprotective Agent Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chondroprotective Agent Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 15. By Type - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 16. By Application – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 20. By Application - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 21. By Region – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 25. By Region - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 26. By Country - North America Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chondroprotective Agent Sales, (K Units), 2017-2022
Table 29. By Country - North America Chondroprotective Agent Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chondroprotective Agent Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chondroprotective Agent Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chondroprotective Agent Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chondroprotective Agent Sales, (K Units), 2023-2028
Table 38. By Country - South America Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chondroprotective Agent Sales, (K Units), 2017-2022
Table 41. By Country - South America Chondroprotective Agent Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chondroprotective Agent Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chondroprotective Agent Sales, (K Units), 2023-2028
Table 46. SANXIN Corporate Summary
Table 47. SANXIN Chondroprotective Agent Product Offerings
Table 48. SANXIN Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. WanTuMing Biological Corporate Summary
Table 50. WanTuMing Biological Chondroprotective Agent Product Offerings
Table 51. WanTuMing Biological Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. TSI Group Corporate Summary
Table 53. TSI Group Chondroprotective Agent Product Offerings
Table 54. TSI Group Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Yantai Dongcheng Corporate Summary
Table 56. Yantai Dongcheng Chondroprotective Agent Product Offerings
Table 57. Yantai Dongcheng Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Focus Chem Corporate Summary
Table 59. Focus Chem Chondroprotective Agent Product Offerings
Table 60. Focus Chem Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. YBCC Corporate Summary
Table 62. YBCC Chondroprotective Agent Product Offerings
Table 63. YBCC Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Runxin Biotechnology Corporate Summary
Table 65. Runxin Biotechnology Chondroprotective Agent Product Offerings
Table 66. Runxin Biotechnology Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ISBA Corporate Summary
Table 68. ISBA Chondroprotective Agent Product Offerings
Table 69. ISBA Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Huiwen Corporate Summary
Table 71. Huiwen Chondroprotective Agent Product Offerings
Table 72. Huiwen Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. QJBCHINA Corporate Summary
Table 74. QJBCHINA Chondroprotective Agent Product Offerings
Table 75. QJBCHINA Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Meitek (Synutra International) Corporate Summary
Table 77. Meitek (Synutra International) Chondroprotective Agent Product Offerings
Table 78. Meitek (Synutra International) Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Hengjie Bio-Pharmaceuticals Corporate Summary
Table 80. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product Offerings
Table 81. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Nippon Zoki Corporate Summary
Table 83. Nippon Zoki Chondroprotective Agent Product Offerings
Table 84. Nippon Zoki Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. GGI Corporate Summary
Table 86. GGI Chondroprotective Agent Product Offerings
Table 87. GGI Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Summit Nutritionals Corporate Summary
Table 89. Summit Nutritionals Chondroprotective Agent Product Offerings
Table 90. Summit Nutritionals Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sioux Pharm Corporate Summary
Table 92. Sioux Pharm Chondroprotective Agent Product Offerings
Table 93. Sioux Pharm Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Ruikangda Biochemical Corporate Summary
Table 95. Ruikangda Biochemical Chondroprotective Agent Product Offerings
Table 96. Ruikangda Biochemical Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Guanglong Biochem Corporate Summary
Table 98. Guanglong Biochem Chondroprotective Agent Product Offerings
Table 99. Guanglong Biochem Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Pacific Rainbow Corporate Summary
Table 101. Pacific Rainbow Chondroprotective Agent Product Offerings
Table 102. Pacific Rainbow Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Chondroprotective Agent Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Chondroprotective Agent Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Chondroprotective Agent Production by Region, 2017-2022 (K Units)
Table 106. Global Chondroprotective Agent Production by Region, 2023-2028 (K Units)
Table 107. Chondroprotective Agent Market Opportunities & Trends in Global Market
Table 108. Chondroprotective Agent Market Drivers in Global Market
Table 109. Chondroprotective Agent Market Restraints in Global Market
Table 110. Chondroprotective Agent Raw Materials
Table 111. Chondroprotective Agent Raw Materials Suppliers in Global Market
Table 112. Typical Chondroprotective Agent Downstream
Table 113. Chondroprotective Agent Downstream Clients in Global Market
Table 114. Chondroprotective Agent Distributors and Sales Agents in Global Market
Table 1. Key Players of Chondroprotective Agent in Global Market
Table 2. Top Chondroprotective Agent Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chondroprotective Agent Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chondroprotective Agent Revenue Share by Companies, 2017-2022
Table 5. Global Chondroprotective Agent Sales by Companies, (K Units), 2017-2022
Table 6. Global Chondroprotective Agent Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chondroprotective Agent Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Chondroprotective Agent Product Type
Table 9. List of Global Tier 1 Chondroprotective Agent Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chondroprotective Agent Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 15. By Type - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 16. By Application – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 20. By Application - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 21. By Region – Global Chondroprotective Agent Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chondroprotective Agent Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chondroprotective Agent Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chondroprotective Agent Sales (K Units), 2017-2022
Table 25. By Region - Global Chondroprotective Agent Sales (K Units), 2023-2028
Table 26. By Country - North America Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chondroprotective Agent Sales, (K Units), 2017-2022
Table 29. By Country - North America Chondroprotective Agent Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chondroprotective Agent Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chondroprotective Agent Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chondroprotective Agent Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chondroprotective Agent Sales, (K Units), 2023-2028
Table 38. By Country - South America Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chondroprotective Agent Sales, (K Units), 2017-2022
Table 41. By Country - South America Chondroprotective Agent Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chondroprotective Agent Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chondroprotective Agent Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chondroprotective Agent Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chondroprotective Agent Sales, (K Units), 2023-2028
Table 46. SANXIN Corporate Summary
Table 47. SANXIN Chondroprotective Agent Product Offerings
Table 48. SANXIN Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. WanTuMing Biological Corporate Summary
Table 50. WanTuMing Biological Chondroprotective Agent Product Offerings
Table 51. WanTuMing Biological Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. TSI Group Corporate Summary
Table 53. TSI Group Chondroprotective Agent Product Offerings
Table 54. TSI Group Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Yantai Dongcheng Corporate Summary
Table 56. Yantai Dongcheng Chondroprotective Agent Product Offerings
Table 57. Yantai Dongcheng Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Focus Chem Corporate Summary
Table 59. Focus Chem Chondroprotective Agent Product Offerings
Table 60. Focus Chem Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. YBCC Corporate Summary
Table 62. YBCC Chondroprotective Agent Product Offerings
Table 63. YBCC Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Runxin Biotechnology Corporate Summary
Table 65. Runxin Biotechnology Chondroprotective Agent Product Offerings
Table 66. Runxin Biotechnology Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ISBA Corporate Summary
Table 68. ISBA Chondroprotective Agent Product Offerings
Table 69. ISBA Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Huiwen Corporate Summary
Table 71. Huiwen Chondroprotective Agent Product Offerings
Table 72. Huiwen Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. QJBCHINA Corporate Summary
Table 74. QJBCHINA Chondroprotective Agent Product Offerings
Table 75. QJBCHINA Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Meitek (Synutra International) Corporate Summary
Table 77. Meitek (Synutra International) Chondroprotective Agent Product Offerings
Table 78. Meitek (Synutra International) Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Hengjie Bio-Pharmaceuticals Corporate Summary
Table 80. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product Offerings
Table 81. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Nippon Zoki Corporate Summary
Table 83. Nippon Zoki Chondroprotective Agent Product Offerings
Table 84. Nippon Zoki Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. GGI Corporate Summary
Table 86. GGI Chondroprotective Agent Product Offerings
Table 87. GGI Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Summit Nutritionals Corporate Summary
Table 89. Summit Nutritionals Chondroprotective Agent Product Offerings
Table 90. Summit Nutritionals Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sioux Pharm Corporate Summary
Table 92. Sioux Pharm Chondroprotective Agent Product Offerings
Table 93. Sioux Pharm Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Ruikangda Biochemical Corporate Summary
Table 95. Ruikangda Biochemical Chondroprotective Agent Product Offerings
Table 96. Ruikangda Biochemical Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Guanglong Biochem Corporate Summary
Table 98. Guanglong Biochem Chondroprotective Agent Product Offerings
Table 99. Guanglong Biochem Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Pacific Rainbow Corporate Summary
Table 101. Pacific Rainbow Chondroprotective Agent Product Offerings
Table 102. Pacific Rainbow Chondroprotective Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Chondroprotective Agent Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Chondroprotective Agent Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Chondroprotective Agent Production by Region, 2017-2022 (K Units)
Table 106. Global Chondroprotective Agent Production by Region, 2023-2028 (K Units)
Table 107. Chondroprotective Agent Market Opportunities & Trends in Global Market
Table 108. Chondroprotective Agent Market Drivers in Global Market
Table 109. Chondroprotective Agent Market Restraints in Global Market
Table 110. Chondroprotective Agent Raw Materials
Table 111. Chondroprotective Agent Raw Materials Suppliers in Global Market
Table 112. Typical Chondroprotective Agent Downstream
Table 113. Chondroprotective Agent Downstream Clients in Global Market
Table 114. Chondroprotective Agent Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Chondroprotective Agent Segment by Type
Figure 2. Chondroprotective Agent Segment by Application
Figure 3. Global Chondroprotective Agent Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chondroprotective Agent Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chondroprotective Agent Revenue, 2017-2028 (US$, Mn)
Figure 7. Chondroprotective Agent Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chondroprotective Agent Revenue in 2021
Figure 9. By Type - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 10. By Type - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chondroprotective Agent Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 13. By Application - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chondroprotective Agent Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 16. By Region - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chondroprotective Agent Sales Market Share, 2017-2028
Figure 19. US Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chondroprotective Agent Sales Market Share, 2017-2028
Figure 24. Germany Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 25. France Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chondroprotective Agent Sales Market Share, 2017-2028
Figure 33. China Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 37. India Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chondroprotective Agent Sales Market Share, 2017-2028
Figure 40. Brazil Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chondroprotective Agent Sales Market Share, 2017-2028
Figure 44. Turkey Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chondroprotective Agent Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chondroprotective Agent by Region, 2021 VS 2028
Figure 50. Chondroprotective Agent Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Chondroprotective Agent Segment by Type
Figure 2. Chondroprotective Agent Segment by Application
Figure 3. Global Chondroprotective Agent Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chondroprotective Agent Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chondroprotective Agent Revenue, 2017-2028 (US$, Mn)
Figure 7. Chondroprotective Agent Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chondroprotective Agent Revenue in 2021
Figure 9. By Type - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 10. By Type - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chondroprotective Agent Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 13. By Application - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chondroprotective Agent Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Chondroprotective Agent Sales Market Share, 2017-2028
Figure 16. By Region - Global Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chondroprotective Agent Sales Market Share, 2017-2028
Figure 19. US Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chondroprotective Agent Sales Market Share, 2017-2028
Figure 24. Germany Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 25. France Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chondroprotective Agent Sales Market Share, 2017-2028
Figure 33. China Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 37. India Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chondroprotective Agent Sales Market Share, 2017-2028
Figure 40. Brazil Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chondroprotective Agent Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chondroprotective Agent Sales Market Share, 2017-2028
Figure 44. Turkey Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chondroprotective Agent Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chondroprotective Agent Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chondroprotective Agent by Region, 2021 VS 2028
Figure 50. Chondroprotective Agent Industry Value Chain
Figure 51. Marketing Channels
